Calumet Specialty Products Partners, L.P. (NASDAQ:CLMT) CFO Purchases $32,625.00 in Stock

Calumet Specialty Products Partners, L.P. (NASDAQ:CLMT - Get Free Report) CFO David Lunin bought 2,500 shares of the stock in a transaction on Tuesday, March 4th. The shares were bought at an average cost of $13.05 per share, for a total transaction of $32,625.00. Following the purchase, the chief financial officer now owns 2,500 shares in the company, valued at $32,625. This trade represents a ∞ increase in their position. The purchase was disclosed in a legal filing with the SEC, which can be accessed through this link.

Calumet Specialty Products Partners Stock Down 3.9 %

Shares of Calumet Specialty Products Partners stock traded down $0.48 during trading on Friday, hitting $11.97. The stock had a trading volume of 830,805 shares, compared to its average volume of 1,442,439. The company has a market capitalization of $1.03 billion, a PE ratio of -4.34 and a beta of 1.88. The stock has a 50 day simple moving average of $17.33 and a 200 day simple moving average of $19.10. Calumet Specialty Products Partners, L.P. has a 1 year low of $9.97 and a 1 year high of $25.29.

Calumet Specialty Products Partners (NASDAQ:CLMT - Get Free Report) last released its quarterly earnings data on Friday, February 28th. The oil and gas company reported ($0.47) earnings per share for the quarter, beating the consensus estimate of ($1.06) by $0.59. The company had revenue of $949.50 million during the quarter, compared to analyst estimates of $921.76 million. The firm's quarterly revenue was down 2.8% compared to the same quarter last year. During the same quarter in the prior year, the company posted ($0.59) EPS. As a group, equities analysts expect that Calumet Specialty Products Partners, L.P. will post -3.02 earnings per share for the current fiscal year.

Remove Ads

Analyst Ratings Changes

Several equities analysts have commented on the stock. HC Wainwright reissued a "buy" rating and set a $33.00 target price on shares of Calumet Specialty Products Partners in a research note on Monday, March 3rd. Wells Fargo & Company lowered their target price on shares of Calumet Specialty Products Partners from $29.00 to $28.00 and set an "overweight" rating on the stock in a research note on Wednesday. UBS Group cut shares of Calumet Specialty Products Partners from a "neutral" rating to a "sell" rating and lowered their target price for the company from $20.50 to $15.00 in a research note on Tuesday, February 4th. StockNews.com raised shares of Calumet Specialty Products Partners to a "sell" rating in a research note on Monday, November 18th. Finally, TD Cowen cut shares of Calumet Specialty Products Partners from a "buy" rating to a "hold" rating and lowered their target price for the company from $26.00 to $16.00 in a research note on Tuesday, March 4th. Two equities research analysts have rated the stock with a sell rating, one has assigned a hold rating and three have assigned a buy rating to the company's stock. According to MarketBeat, the company currently has a consensus rating of "Hold" and a consensus target price of $21.40.

Calumet Specialty Products Partners Company Profile

Calumet, Inc engages in the manufacturing, formulating, and marketing of a diversified slate of specialty branded products and renewable fuels to customers across a broad range of consumer-facing and industrial markets. It operates through the following segments: Specialty Products & Solutions, Performance Brands, Montana/Renewables, and Corporate.